Illumina is trading 4.35% up now at $231.97, driven by continued buying ahead of its S&P 500 inclusion, effective before the September 21, 2026 open.
- Index-tracking funds may need to purchase shares, supporting institutional demand.
- UBS’s September 9 upgrade to Buy with a $260 price target adds bullish momentum.
- No newer major company announcement was identified on September 16; broader market is modestly positive, but the company-specific index catalyst appears stronger.